[HTML][HTML] Ferroptosis: a double-edged sword mediating immune tolerance of cancer
Q Dang, Z Sun, Y Wang, L Wang, Z Liu, X Han - Cell death & disease, 2022 - nature.com
The term ferroptosis was put forward in 2012 and has been researched exponentially over
the past few years. Ferroptosis is an unconventional pattern of iron-dependent programmed …
the past few years. Ferroptosis is an unconventional pattern of iron-dependent programmed …
Update on prognostic and predictive biomarkers of breast cancer
Y Hou, Y Peng, Z Li - Seminars in diagnostic pathology, 2022 - Elsevier
Breast cancer represents a heterogeneous group of human cancer at both histological and
molecular levels. Estrogen receptor (ER), progesterone receptor (PR) and human epidermal …
molecular levels. Estrogen receptor (ER), progesterone receptor (PR) and human epidermal …
[HTML][HTML] Immunotherapy for colorectal cancer: mechanisms and predictive biomarkers
Simple Summary Late-stage colorectal cancer treatment often involves chemotherapy and
radiation that can cause dose-limiting toxicity, and therefore there is great interest in …
radiation that can cause dose-limiting toxicity, and therefore there is great interest in …
[HTML][HTML] PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application
Immune-checkpoint inhibitors targeting the PD-1/PD-L1 axis have brought significant clinical
benefit in many solid cancer types, including gastrointestinal malignancies. However, it has …
benefit in many solid cancer types, including gastrointestinal malignancies. However, it has …
A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy …
H Takahashi, H Watanabe… - The Journal of …, 2022 - Wiley Online Library
Abstract Programmed cell death‐1 (PD‐1) and its ligand (PD‐L1) are significant mediators
of immune suppression in the tumor microenvironment. We focused on the immunological …
of immune suppression in the tumor microenvironment. We focused on the immunological …
The scope of liquid biopsy in the clinical management of oral cancer
NT Baby, A Abdullah, S Kannan - … Journal of Oral and Maxillofacial Surgery, 2022 - Elsevier
Oral squamous cell carcinoma (OSCC) is one of the most prevalent forms of head and neck
cancer, and it remains a leading cause of death in developing countries. Failure to detect the …
cancer, and it remains a leading cause of death in developing countries. Failure to detect the …
[HTML][HTML] The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
X Sun, L Liu, T Wan, Q Huang, J Chen, R Luo… - Cancer Cell …, 2022 - Springer
Background We investigate the correlation between programmed cell death-ligand 1 (PD-
L1) and tumor-associated immune cell (TAIC) density in small-cell neuroendocrine …
L1) and tumor-associated immune cell (TAIC) density in small-cell neuroendocrine …
[Retracted] IFN‐γ induces PD‐L1 through p38/JNK/ERK signaling pathways and counteracts the tumor promoting effect mediated by PD‐L1 in Glioblastoma
H Jia, X Xie, L Wang, L Wang… - Computational …, 2022 - Wiley Online Library
Glioblastoma is the most malignant primary glioma. Conventional treatment methods that
include surgery, radiotherapy, and chemotherapy have a limited curative effect on the tumor …
include surgery, radiotherapy, and chemotherapy have a limited curative effect on the tumor …
Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR …
M Jary, W Liu, D Yan, I Bai, A Muranyi… - Molecular …, 2022 - Wiley Online Library
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma
GN Al-Jussani, A Alsughayer… - The International …, 2022 - journals.sagepub.com
Background Few studies have addressed the clinicopathological features of colorectal
cancer (CRC) that express programed death-ligand 1 (PD-L1). Various assays and scoring …
cancer (CRC) that express programed death-ligand 1 (PD-L1). Various assays and scoring …